BOOSTRIX POLIO INJ.SUSP Grekland - grekiska - Εθνικός Οργανισμός Φαρμάκων

boostrix polio inj.susp

glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - diphtheria toxoid, adsorbed; tetanus toxoid; pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - diphtheria toxoid, adsorbed 0 => 2iu; tetanus toxoid 0 => 20iu; pertussis toxoid (pt) 8mcg; filamentous haemagglutinin (fha) 8mcg; pertactin (69 kda outer membrane protein-69k) 2,5mcg; inactivated poliovirus vacc type i 40du; inactivated poliovirus vacc type ii 8du; inactivated poliovirus vacc type iii 32du - diphtheria-pertussis-poliomyelitis-tetanus

TETRAVAC INJ.SUSP (1 DOSE) 0,5ML PF.SYR Grekland - grekiska - Εθνικός Οργανισμός Φαρμάκων

tetravac inj.susp (1 dose) 0,5ml pf.syr

ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ Βασ.Σοφίας 127,, 115 21 115 21, Αθήνα 6462281, 6430044 - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (1 dose) 0,5ml pf.syr - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - diphtheria-pertussis-poliomyelitis-tetanus

TETRAVAC (ΕΜΒΟΛΙΟ) INJ.SUSP (1ΔΟΣΗ)0,5ML PF.SYR. Grekland - grekiska - Εθνικός Οργανισμός Φαρμάκων

tetravac (εμβολιο) inj.susp (1δοση)0,5ml pf.syr.

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (1ΔΟΣΗ)0,5ml pf.syr. - purified diphteria toxoid 20iu; purified tetanus toxoid 40iu; purified pertussis toxoid (pt xd) 25mcg; filamentous haemagglutinin (fha) 25mcg; inactivated poliovirus vacc type i 29du; inactivated poliovirus vacc type ii 7du; inactivated poliovirus vacc type iii 26du - diphtheria-pertussis-poliomyelitis-tetanus

REPEVAX INJ.SU.PFS Grekland - grekiska - Εθνικός Οργανισμός Φαρμάκων

repevax inj.su.pfs

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - diphtheria toxoid, adsorbed; tetanus toxoid, adsorbed; purified pertussis toxoid (pt xd); adsorbed purified filamentous haemagglutinin (fha); adsorbed purified pertactin (prn); adsorbed purified fimbrial agglutinogens 2+3 (fim); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; aluminium phosphate - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - diphtheria toxoid, adsorbed 2iu; tetanus toxoid, adsorbed 20iu; purified pertussis toxoid (pt xd) 2,5mcg; adsorbed purified filamentous haemagglutinin (fha) 5mcg; adsorbed purified pertactin (prn) 3mcg; adsorbed purified fimbrial agglutinogens 2+3 (fim) 5mcg; inactivated poliovirus vacc type i 29u; inactivated poliovirus vacc type ii 7u; inactivated poliovirus vacc type iii 26u; aluminium phosphate 1,5mg - diphtheria-pertussis-poliomyelitis-tetanus

INFANRIX IPV+HIB IN PRE-FILLED SYRINGE POWDER & SUSPENSION FOR SUSPENSION FOR INJECTION Cypern - grekiska - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

infanrix ipv+hib in pre-filled syringe powder & suspension for suspension for injection

glaxosmithkline biologicals sa (0000003483) rue de l΄ institut 89, rixensart, b-1330 - diphtheria toxoid; poliomyelitis virus type 3; poliomyelitis virus type 2; poliomyelitis virus type 1; haemophilus infl. type b polys.conj.t.toxoid; tetanus toxoid; pertactin (69kda outer membrane protein-69k); filamentous haemagglutinin (fha); pertussis toxoid(pt) - powder & suspension for suspension for injection - in pre-filled syringe - diphtheria toxoid (8000000804) 30iu; poliomyelitis virus type 3 (8000000485) 32du; poliomyelitis virus type 2 (8000000484) 8du; poliomyelitis virus type 1 (8000000483) 40du; haemophilus infl. type b polys.conj.t.toxoid (8000001810) 10mcg; tetanus toxoid (8000024353) 40iu; pertactin (69kda outer membrane protein-69k) (8000001814) 8mcg; filamentous haemagglutinin (fha) (8000001813) 25mcg; pertussis toxoid(pt) (8000001811) 25mcg - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

TETRAXIM SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE Cypern - grekiska - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

tetraxim suspension for injection in pre-filled syringe

sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - diphtheria toxoid; tetanus toxoid; bordetella pertussis antigens toxoid; bordetella pertussis antigens filamentous haemagglutinin; formalinavd\dat poliovirus typ 1 (stam brunenders); formalinavd\dat poliovirus typ 2 (stam mef1); formalinavd\dat poliovirus typ 3 (stam saukett) - suspension for injection in pre-filled syringe - diphtheria toxoid (8000000804) 30iu; tetanus toxoid (8000040440) 40iu; bordetella pertussis antigens toxoid (8000002964) 25ug; bordetella pertussis antigens filamentous haemagglutinin (8000003163) 25ug; formalinavd\dat poliovirus typ 1 (stam brunenders) (8000037458) 40du; formalinavd\dat poliovirus typ 2 (stam mef1) (8000037469) 8du; formalinavd\dat poliovirus typ 3 (stam saukett) (8000037470) 32du - diphtheria-pertussis-poliomyelitis-tetanus

Inrebic Europeiska unionen - grekiska - EMA (European Medicines Agency)

inrebic

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - Αντινεοπλασματικοί παράγοντες - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

INFANRIX INJ.SUSP 0,5ML Grekland - grekiska - Εθνικός Οργανισμός Φαρμάκων

infanrix inj.susp 0,5ml

ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522 - diphtheria toxoid, adsorbed; tetanus toxoid; pertussis acellular (pertussis toxoid, fha, 69 kda outer membrane protein) - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 0,5ml - diphtheria toxoid, adsorbed; tetanus toxoid; pertussis acellular (pertussis toxoid, fha, 69 kda outer membrane protein)

DIFTAVAX INJ.SUSP (4+40)IU Grekland - grekiska - Εθνικός Οργανισμός Φαρμάκων

diftavax inj.susp (4+40)iu

vianex a.e. Οδός Τατοίου, 146 71 Ν. Ερυθραία 210-8009111 - purified diphteria toxoid; purified tetanus toxoid - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (4+40)iu - purified diphteria toxoid; purified tetanus toxoid

BOOSTRIX INJ.SU.PFS 0,5ml/PF.SYR.(1DOSE) Grekland - grekiska - Εθνικός Οργανισμός Φαρμάκων

boostrix inj.su.pfs 0,5ml/pf.syr.(1dose)

glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - diphtheria toxoid, adsorbed; tetanus toxoid; pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - 0,5ml/pf.syr.(1dose) - diphtheria toxoid, adsorbed 0 => 2iu; tetanus toxoid 0 => 20iu; pertussis toxoid (pt) 8mcg; filamentous haemagglutinin (fha) 8mcg; pertactin (69 kda outer membrane protein-69k) 2,5mcg - pertussis, purified antigen, comb. with toxoids